Paper Details

  1. Home
  2. Paper Details

The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.

Author: BuckoAlicia, Herz-RuelasMaira E, JarrattMichael T, JonesTerry M, Ocampo-CandianiJorge, PollakRichard A, Toledo-BahenaMirna E, ZaneLee T

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Three clinical studies of 336 patients with toenail onychomycosis found that tavaborole topical solution demonstrated favorable efficacy and safety. Treatment success rates at day 180 were higher with tavaborole 2.5%, 5.0%, and 7.5% compared to vehicle. Tavaborole 5% showed promising results and was further investigated in phase 3 studies.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To assess the potential efficacy, safety, and optimal dosing concentration of tavaborole, a novel, boron-based pharmaceutical agent with broad-spectrum antifungal activity, for the treatment of onychomycosis of the toenail due to dermatophytes. METHODS: One double-blind, randomized, vehi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/25226015

データ提供：米国国立医学図書館（NLM）

Tavaborole: A New Oasis in the Desert of Toenail Onychomycosis

Toenail onychomycosis, a fungal infection of the toenail, can be a stubborn and unsightly condition that affects millions worldwide. This article reports on phase 2 studies evaluating the efficacy and safety of tavaborole, a novel boron-based antifungal agent, for the topical treatment of toenail onychomycosis. The studies showed promising results, with tavaborole demonstrating favorable efficacy and safety at different concentrations and application frequencies. While further research is needed, these findings suggest that tavaborole may offer a new and effective treatment option for this challenging condition.

A New Path in the Desert: Tavaborole Shows Promise

The study's results demonstrate the potential for tavaborole to become a valuable addition to the therapeutic arsenal for toenail onychomycosis. Its favorable efficacy and safety profile, particularly at a 5% concentration, suggest that it may be an effective and well-tolerated treatment option for patients. However, it is crucial to await the results of larger, phase 3 studies to confirm its efficacy and safety in a broader population.

Navigating the Desert of Toenail Infections: A New Hope

The development of tavaborole offers a glimmer of hope for patients struggling with toenail onychomycosis. While further research is needed to solidify its efficacy and safety, it represents a promising new therapeutic option. It is important to discuss treatment options with a healthcare professional to determine the best course of action based on individual needs and medical history.

Dr. Camel's Conclusion

Toenail onychomycosis, like a stubborn sand dune, can be difficult to conquer. Tavaborole, a new antifungal agent, offers a promising oasis in this desert, potentially providing a safe and effective solution for patients seeking relief from this challenging condition.

Date :
  1. Date Completed 2015-06-22
  2. Date Revised 2016-11-25
Further Info :

Pubmed ID

25226015

DOI: Digital Object Identifier

S1545961614P1124X

Related Literature

Article Analysis
・Effects of tavaborole topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.